• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe

Mergers & Acquisitions

Steris inks $2.1B deal for operating room supplier Xodus Medical

October 13, 2026 By Conor Hale

Steris (NYSE: STE) aims to boost its portfolio of hospital consumables and operating room products with a $2.1 billion deal to acquire Xodus Medical. The Pennsylvania-based Xodus provides a variety of products for patient positioning during surgery, including the Pink Pad cushioning systems designed to reduce the risk of pressure injuries, in addition to bed […]

Filed Under: Business/Financial News, Mergers & Acquisitions, Surgical Tagged With: Steris

Stryker dives into soft-tissue robotics with $400M play for CMR Surgical’s Versius

October 13, 2026 By Conor Hale

Stryker (NYSE: SYK) is diving into soft-tissue robotics with a $400 million investment in CMR Surgical, netting exclusive rights to sell its Versius platform in the U.S. and pocketing an option to acquire the company in the future. The alliance comes shortly after Medtronic agreed to put $700 million into Cornerstone Robotics and its Sentire […]

Filed Under: Business/Financial News, Featured, Gynecological, Mergers & Acquisitions, News Well, Robotic-Assisted, Surgical, Surgical Robotics, Women's Health Tagged With: CMR Surgical, Robotic Surgery, Stryker, surgical robot, surgical robotics, surgical robotics platforms

iRhythm completes acquisition of VitalConnect

October 6, 2026 By Chris Newmarker

iRhythm (Nasdaq: IRTC) announced this week that it has completed its $287.5 million acquisition of cardiac monitoring tech company VitalConnect. In a news release posted yesterday, iRhythm CEO Quentin Blackford described the deal close as an important milestone as the San Francisco–based company evolves past being a wearable heart patch monitor company to providing a […]

Filed Under: Business/Financial News, Cardiovascular, Diagnostics, Digital Health, Mergers & Acquisitions Tagged With: iRhythm, VitalConnect

Wandercraft acquires exoskeleton rival Ekso Bionics

October 5, 2026 By Conor Hale

Wandercraft has acquired fellow exoskeleton maker Ekso Bionics, with the goal of forming an international robotic mobility player. The companies say Ekso’s U.S. commercial presence will bolster Wandercraft’s footprints in Europe, the Middle East and Africa. The deal’s financial terms were not disclosed. Their respective EksoNR and Atalante X systems are currently deployed at more […]

Filed Under: Business/Financial News, Featured, Mergers & Acquisitions, Orthopedics, Prosthetics Tagged With: Ekso Bionics, exoskeletons, wandercraft

GE HealthCare to buy Sofie Biosciences in $945M radiopharmaceutical play

October 5, 2026 By Conor Hale

GE HealthCare (Nasdaq: GEHC) aims to bolster its radiopharmaceutical supply chain with a $945 million cash deal to buy Sofie Biosciences and its U.S. network of manufacturing sites. The goal is to obtain last-mile logistics for radioactive imaging agents that have a short half-life and need to be produced as close to patients as possible. […]

Filed Under: Business/Financial News, Cardiovascular, Diagnostics, Distribution, Imaging, Mergers & Acquisitions, Oncology, Pharmaceutical Tagged With: GE Healthcare, PET scans, Sofie Bioscience

Terumo to buy Arsenal Medical and its liquid embolic brain bleed system

September 30, 2026 By Conor Hale

Terumo has inked a deal for its neurovascular subsidiary to acquire Arsenal Medical and its liquid embolic approach for treating certain brain bleeds. Arsenal’s investigational NeoCast is being developed for chronic and subacute subdural hematoma, through the blocking of the brain’s middle meningeal artery, or MMA. Terumo Neuro describes the solvent-free, non-adhesive biomaterial as a […]

Filed Under: Business/Financial News, Cardiovascular, Mergers & Acquisitions, Neurological, Vascular Tagged With: acquisitions, Arsenal Medical, mergers, Neurovascular, Terumo, Terumo Neuro

Johnson & Johnson drops LAA assets following suspended pivotal study

September 17, 2026 By Conor Hale

Johnson & Johnson MedTech (NYSE:JNJ) is offloading a left-atrial appendage closure system it paid $400 million upfront for nearly three years ago, abandoning plans to compete in the space dominated by Boston Scientific and Abbott. Acquired through its late-2023 buy of the developer Laminar, J&J’s Biosense Webster then backed a pivotal study that sought to […]

Filed Under: Business/Financial News, Cardiovascular, Catheters, Featured, Implants, Mergers & Acquisitions, Structural Heart, Structural Heart Tagged With: Johnson & Johnson, Laminar, Sante Ventures

Johnson & Johnson MedTech reportedly could sell DePuy Synthes to Apollo

September 14, 2026 By Chris Newmarker

Johnson & Johnson MedTech (NYSE: JNJ) is in talks with Apollo Global Management to sell all or part of its DePuy Synthes orthopedics business, according to media reports citing anonymous sources. A Bloomberg report said discussions involved the orthopedics unit, while The Wall Street Journal specifically mentioned the hips and knees business. The deal would […]

Filed Under: Business/Financial News, Featured, Mergers & Acquisitions, Orthopedic Implants, Orthopedics Tagged With: DePuy Synthes, Johnson & Johnson, Johnson & Johnson MedTech, private equity

Enovis to acquire eCential Robotics for €155 million, plans to bring surgical robot to market

September 1, 2026 By Julia Rock-Torcivia

Enovis (NYSE: ENOV) has entered into a binding offer to acquire surgical robotics technology developer eCential Robotics for €155 million ($175 million), with up to €35 million ($41 million) in milestone payments, the company announced today. The transaction is expected to close by the end of 2026, subject to regulatory approvals. The move would launch […]

Filed Under: Artificial Intelligence (AI), Business/Financial News, Featured, Mergers & Acquisitions, Orthopedics, Spine, Surgical, Surgical Robotics Tagged With: eCential, eCential Robotics, Enovis, surgical robot, surgical robotic platforms, surgical robotics

J&J MedTech is rebranding Shockwave Medical

September 1, 2026 By Jim Hammerand

Johnson & Johnson plans to rebrand Shockwave Medical on Oct. 1, the device and drug developer said. “Shockwave Medical will be rebranded to Johnson & Johnson MedTech, and our technologies will be known as circulatory restoration solutions,” Shockwave said on LinkedIn today. “Although our name and color may be changing, our commitment to cardiovascular innovation […]

Filed Under: Cardiovascular, Featured, Mergers & Acquisitions, News Well, Vascular Tagged With: Johnson & Johnson, Johnson & Johnson MedTech, Johnson and Johnson, Shockwave Medical

Stryker to acquire ZuriMed to boost shoulder offerings

August 31, 2026 By Chris Newmarker

Stryker (NYSE:SYK) will acquire privately held ZuriMed and its FiberLocker system for rotator cuff augmentation, the ortho and surgical tech giant said after market close today. The FiberLock instrument uses a reciprocating needle to push implant fibers into the underlying soft tissue, securing the patch across the entire patch–tendon interface. The result, according to ZuriMed’s […]

Filed Under: Business/Financial News, Featured, Mergers & Acquisitions, Orthopedics Tagged With: Stryker, ZuriMed

  • Page 1
  • Page 2
  • Page 3
  • Interim pages omitted …
  • Page 312
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy